最新消息

USA: Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions - August/September 2025

USA: Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions - August/September 2025

  • 2025-09-24 07:20:49

The FDA has issued draft guidance on marketing submissions for AI-enabled device software functions (AI-DSFs), with a focus on using a predetermined change control plan (PCCP). A PCCP allows manufacturers to plan and manage software changes in a predictable and controlled way, making regulatory review smoother and device performance more reliable.

了解更多
TAIWAN: Product Registration Guidance for Artificial Intelligence/Machine Learning-Based Computer-assisted Detection (CADe) and Diagnosis (CADx) Software – October/November 2022

TAIWAN: Product Registration Guidance for Artificial Intelligence/Machine Learning-Based Computer-assisted Detection (CADe) and Diagnosis (CADx) Software – October/November 2022

  • 2022-10-24 09:56:11

TFDA has recently announced a specific product registration guidance for AI/ML-based computer-assisted detection (CADe) and computer-assisted diagnosis (CADx) software. Through the application of AI and ML-based technologies in detective or diagnostic medical devices, these kinds of products could be essential for medical personnel by decreasing required reading time with better diagnostic performance.

了解更多